G. Miller

Oncology · Cancer Discovery · 2012–2019

A researcher in the Science corpus: 5 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom G. Miller trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Ostrand-Rosenberg (in Immunology)
  2. P. Sinha (in Immunology)

Papers from G. Miller's perspective

Ordered by how strongly the researchers G. Miller trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Myeloid-derived-suppressor cells as regulators of the immune system (Nature reviews. Immunology)
  2. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. (Cancer Cell)
  3. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. (Cancer Research)
  4. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. (Cancer Cell)
  5. Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells (Immunological Reviews)
  6. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. (Genes & Development)
  7. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors (Nature Genetics)
  8. Statistical significance for genomewide studies (Proceedings of the National Academy of Sciences of the United States of America)
  9. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. (Journal of Clinical Oncology)
  10. Pancreatic cancer. (Clinical Chemistry)

Their papers